Arvinas, Inc.
ARVN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001655759
No open-market purchases or sales by Arvinas, Inc. insiders were filed in the last 90 days; 201 institutions reported holding it in 13F filings for Q2 2026, worth $468.7M in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Arvinas, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 213
- +60 vs. Q3 2023
- Shares held
- 64.9M
- +16.1M (+33.0%) vs. Q3 2023
- Total value
- $2.67B
- +$1.71B (+178.5%) vs. Q3 2023
- New holders
- 84
- 67 more added
- Sold out
- 24
- 42 more reduced
2 institutions that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ARVN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 201 | $468.7M |
| Q1 2026 | 207 | $572.6M |
| Q4 2025 | 206 | $662.9M |
| Q3 2025 | 211 | $570.7M |
| Q2 2025 | 215 | $513.8M |
| Q1 2025 | 216 | $456.7M |
| Q4 2024 | 199 | $1.47B |
| Q3 2024 | 206 | $1.78B |
| Q2 2024 | 207 | $1.89B |
| Q1 2024 | 223 | $2.84B |
| Q4 2023 | 213 | $2.67B |
| Q3 2023 | 155 | $959.0M |
| Q2 2023 | 156 | $1.16B |
| Q1 2023 | 171 | $1.34B |
| Q4 2022 | 162 | $1.71B |
| Q3 2022 | 174 | $2.22B |
| Q2 2022 | 172 | $2.08B |
| Q1 2022 | 179 | $3.16B |
| Q4 2021 | 199 | $3.69B |
| Q3 2021 | 205 | $3.64B |
| Q2 2021 | 181 | $3.52B |
| Q1 2021 | 181 | $2.88B |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Arvinas, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,289,521 | $53.1M | 42.75% | 00.0% | Unchanged |
| ArrowMark Colorado Holdings LLC | 1,569,895 | $64.6M | 0.71% | −517,397−24.8% | Reduced |
| Nextech Invest AG | 1,695,645 | $69.8M | 13.00% | +1,408,394+490.3% | Added |
| JPMorgan Chase & Co | 2,172,829 | $89.4M | 0.01% | +183,582+9.2% | Added |
| FMR LLC | 2,244,019 | $92.4M | 0.01% | −2,624,276−53.9% | Reduced |
| Citadel Advisors LLC | 2,439,981 | $99.3M | 0.10% | +1,815,403+290.7% | Added |
| Bellevue Group AG | 2,507,731 | $103.2M | 1.58% | +382,531+18.0% | Added |
| Avidity Partners Management LP | 2,985,117 | $122.9M | 4.70% | +370,157+14.2% | Added |
| Price T Rowe Associates Inc | 3,832,123 | $157.7M | 0.02% | +1,143,452+42.5% | Added |
| RTW Investments, LP | 4,213,483 | $173.4M | 2.71% | +4,213,483 | New |
| Vanguard Group Inc | 4,851,390 | $199.7M | 0.00% | +243,167+5.3% | Added |
| BlackRock Inc. | 5,354,864 | $220.4M | 0.01% | +385,256+7.8% | Added |
| EcoR1 Capital, LLC | 6,726,491 | $276.9M | 7.19% | +1,259,428+23.0% | Added |
| Baker Bros. Advisors LP | 0 | $0 | 0.00% | −413,481−100.0% | Sold out |
| 5AM Venture Management, LLC | 0 | $0 | 0.00% | −320,000−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −215,893−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −191,883−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | – | Sold out |
| Capula Management Ltd | 0 | $0 | 0.00% | −41,160−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −34,964−100.0% | Sold out |
| Alpha DNA Investment Management LLC | 0 | $0 | 0.00% | −26,759−100.0% | Sold out |
| AE Wealth Management LLC | 0 | $0 | 0.00% | −23,645−100.0% | Sold out |
| Mach-1 Financial Group, Inc. | 0 | $0 | 0.00% | −23,577−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Skandinaviska Enskilda Banken AB (publ) | 0 | $0 | 0.00% | −19,010−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −14,607−100.0% | Sold out |
| Numerai GP LLC | 0 | $0 | 0.00% | −12,395−100.0% | Sold out |
| Centiva Capital, LP | 0 | $0 | 0.00% | −11,742−100.0% | Sold out |
| Public Employees Retirement System of Ohio | 0 | $0 | 0.00% | −3,280−100.0% | Sold out |
| Quarry LP | 0 | $0 | 0.00% | −2,518−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −2,400−100.0% | Sold out |
| BluePath Capital Management, LLC | 0 | $0 | 0.00% | −1,447−100.0% | Sold out |
| Meeder Asset Management Inc | 0 | $0 | 0.00% | −1,236−100.0% | Sold out |
| KBC Group NV | 0 | $0 | 0.00% | −758−100.0% | Sold out |
| Syntax Research, Inc. | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Global Retirement Partners, LLC | 0 | $0 | 0.00% | −36−100.0% | Sold out |
| Glassman Wealth Services | 0 | $0 | 0.00% | −31−100.0% | Sold out |
| International Biotechnology Trust PLC | – | – | – | – | Not filed |
| Foster Dykema Cabot & Co Inc | – | – | – | – | Not filed |